ACADIA Pharmaceuticals Inc. vs Kinder Morgan Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Kinder Morgan Inc trades at $31.6 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 13.8× ACADIA Pharmaceuticals Inc.'s market cap, and Kinder Morgan Inc pays a 3.75% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | KMI | |
|---|---|---|
Market Cap | $5.07B | $70.10B |
Sector | Health | Energy |
52-Week High | $29.41 | $34.31 |
52-Week Low | $20.06 | $25.84 |
Enterprise Value | $4.19B | $102.15B |
Dividend Yield | — | 3.75% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →